I'm not sure why they are posting these updated tweets that have no direct relationship to the performance of Imugene (especially when they are about T-cells not B-cells.) Everyone knows that immuno-oncology is the #1 place to be in cancer research. Kind of a pathetic way to try and keep interest. Let the science do the talking Leslie.
Hard to believe?, page-129
-
- There are more pages in this discussion • 12 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.9¢ |
Change
0.001(2.63%) |
Mkt cap ! $386.7M | |||
| Open | High | Low | Value | Volume |
| 3.8¢ | 3.9¢ | 3.7¢ | $268.8K | 7.053M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 13 | 1165360 | 3.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 742337 | 6 |
View Market Depth
| Last trade - 11.35am 27/11/2024 (20 minute delay) ? |
| IMU (ASX) Chart |
